Background China has undergone rapid demographic and epidemiological changes in the past few decades, including striking declines in fertility and child mortality and increases in life expectancy at birth. Popular discontent with the health system has led to major reforms. To help inform these reforms, we did a comprehensive assessment of disease burden in China, how it changed between 1990 and 2010, and how China's health burden compares with other nations.
Introduction
China has made enormous strides in improving health in the past few decades. Between 1970 and 2010, male life expectancy increased from 60·4 years to 72·9 years and female life expectancy increased from 63·5 years to 79·0 years; 1 the under-5 mortality rate reduced from 100·6 per 1000 to 12·9 per 1000; 1 and the total fertility rate declined from 4·77 to 1·64 children per woman. 2 Rapidly increasing income per head, an ageing population, and longer lifespans have led to a rapid change in the health profi le of the nation. Some counties within the country, however, remain relatively poor and continue to have a set of health challenges dominated by communicable, maternal, and neonatal causes. 3, 4 China needs to understand and formulate a long-range strategy to tackle several challenges in public health and medical care at the same time.
Before health-care reform was announced in 2009, 5 the Chinese Government was faced with widespread public discontent stemming from unaff ordable access to health care and growing inequalities in access to health care and health status across regions and populations. [6] [7] [8] [9] Health improvement fell short of what China's rapid economic growth should have aff orded. 10 Some previously eliminated infectious diseases re-emerged 11 and incidence of some non-communicable diseases increased. 12, 13 The 2002-03 severe acute respiratory syndrome (SARS) outbreak was a wake-up call exposing the inadequacies of the public health protection and surveillance system, and emphasising the important role for government in guidance of the evolution of health in China. Health system reforms focused on delivering improved access to quality clinical care 14 are now underway but can be better informed by a broad assessment of China's progress in health.
Several data systems provide substantial detail about levels and trends in health in China, including various national surveys of health, civil registration, medical certifi cation of causes of death in some cities and counties, 15 the Disease Surveillance Points system, 16 a sophisticated infectious disease surveillance network, 17 population-based cancer registries, 18 a maternal and child surveillance system, 17 and demographic surveys 19, 20 and censuses. 21, 22 Despite these data systems, a comprehensive and comparable assessment of health challenges and how they change over time is not available. Opportunities to compare China's health performance with other countries to learn where China has done well and where scope for improvement exists have thus been limited.
In this report, we use the results of the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) to examine in detail the transformation of health in China from 1990 to 2010 and to benchmark health challenges in China to 18 major high-income and rapidly developing countries that are members of the G20.
Methods

Overview
Detail on the data, approaches to enhancing data quality and comparability, and statistical modelling and metrics for the GBD 2010 have been reported elsewhere. 1, [23] [24] [25] [26] [27] [28] [29] In brief, GBD 2010 lists 291 diseases and injuries, organised in a hierarchy. For each of these causes, up to 24 sequelae exist that are clinical outcomes related to specifi c diseases and injuries, such as neuropathy due to diabetes. The study included 1160 sequelae.
The 2010 GBD study used numerous metrics to report results on health loss related to specifi c causes of disease and injury: deaths and death rates, years of life lost due to premature mortality (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs). YLLs are computed by multiplying the number of deaths in each age group by a reference life expectancy at that age. The life expectancy at birth in the reference life table is 86·0 years based on the lowest reported death rates for each age group across countries in 2010, and is intended to represent an achievable pattern of mortality. 26 Years lived with disability are calculated from the prevalence of a sequela multiplied by the disability weight for that sequela. Disability weights are based on surveys of the general population. 27 DALYs are the sum of YLLs and YLDs. The GBD uses another indicator, healthy life expectancy (HALE), to summarise overall population health in one number, accounting for both length of life and levels of ill health at diff erent ages. 28 
Mortality
Wang and colleagues 1 provide a detailed description on how rates of age-specifi c mortality have been estimated for each sex, country, and year. Appendix p 1 provides details on each of the sources available for measurement of the under-5 mortality rate, and appendix pp 2-3 provides similar information on measuring the probability of death between ages 15 years and 60 years. Available national data sources on the age pattern of mortality provide similar distributions of deaths for individuals aged 15-79 years (appendix pp [4] [5] .
Causes of death
We calculated numbers of deaths and YLLs based on underlying cause of death estimates for 235 of 291 causes of mortality, and for 20 age groups, both sexes, and 187 countries. 24 The appendix p 11 provides a listing of the major sources of information used to assess causes of death in China since 1980, including population-based cancer registry data. We assessed the quality of each data source, and mapped the codes for various Chinese variants of the International Classifi cation of Diseases and Injuries (ICD) tabulation lists to the GBD 2010 cause list. We reassigned deaths assigned to ill-defi ned diagnoses or to disorders that are not likely to be underlying causes of death with standard algorithms. 30, 31 GBD 2010 provides the most comprehensive eff ort to date to enhance the comparability of cause of death data across countries because it adjusts for revisions of the ICD and the redistribution of garbage codes. Garbage codes are causes of death that should not be identifi ed as underlying causes of death but have been entered as the underlying cause of death on death certifi cates. Classic examples of garbage codes include senility or cardiopulmonary arrest. Uncertainty in cause of death estimates has been captured with standard simulation methods by taking 1000 draws 32 for each age, sex, country, year, and cause. 24 Final uncertainty for death numbers and YLLs also refl ects uncertainty in the levels of allcause mortality in each age-sex-country-year.
YLDS and HALE
We undertook prevalence estimation for each sequela with a systematic analysis of published and available unpublished data sources for prevalence, incidence, remission, and excess mortality. For most sequelae, we made estimates on the basis of a database for all age-sex-country-year groups, with a Bayesian metaregression technique developed for the GBD 2010 (DisMod-MR). Several data sources have been used for the estimates of YLDs in China, including published studies, [33] [34] [35] [36] [37] [38] multiple national surveys, 39 ,40 a set of 46 cancer registries, [41] [42] [43] [44] [45] [46] Prevention (CDC) surveillance system. [47] [48] [49] [50] [51] [52] [53] The eff ects of treatment depending on the cause are captured through changes in prevalence, changes in the severity distribution across sequelae (eg, for chronic obstructive pulmonary disease), and for some injuries diff erent disability weights for treated and untreated outcomes. Access to treatment for injuries is estimated on the basis of an indicator of access to health systems. 29 For GBD 2010, disability weights were measured for 220 unique health states that cover the 1160 disease and injury sequelae. 27 Disability weights were generated from more than 30 000 respondents collected through population-based surveys in fi ve countries-USA, Peru, Tanzania, Bangladesh, and Indonesia-and an open internet survey. 271 respondents of the internet survey were from China. Uncertainty in the disability weight for each sequela has been propagated into the estimates of YLDs for each disease and injury. We combined information about age-specifi c mortality rates, and about overall age-specifi c YLDs per person into the overall measure of health expectancy, HALE, using a standard approach to extending the life table to capture adjustments for non-fatal health outcomes. 28
Risk factors
Deaths, YLLs, YLDs, and DALYs attributable to 67 risk factors or clusters of risk factors were assessed with three key inputs. 23 First, for each risk-outcome pair, relative risks of mortality or morbidity, or both, were estimated on the basis of meta-analyses of the published literature. Second, each risk factor exposure distribution in each country, age, and sex group was estimated on the basis of published and unpublished data sources with mostly Bayesian estimation methods. 23 For China, key sources included the 2002 China National Nutrition and Health Survey, the China Global Youth Tobacco Survey, the Second National Health Services Survey, the 1996 Global Youth Tobacco Survey, the 1996 National Prevalence Survey, the After-MONICA, the INTERSALT Beijing, the INTERMAP Beijing, and the 2000 and 2005 national censuses. Third, we estimated attributable deaths or DALYs by comparing the present distribution of exposure to a theoretical minimum risk counterfactual distribution of exposure selected for each risk factor. Each risk factor or cluster of risk factors was analysed separately and therefore the sum of attributable fractions for a disease or injury can be greater than 100%. Uncertainty in the relative risks, exposure estimates, and theoretical minimum risk distributions and uncertainty in the background outcome rates have been propagated into the fi nal estimates.
Benchmarking
For outcomes measured for specifi c age groups (deaths, YLLs, YLDs, and DALYs), we directly computed age-standardised rates with the WHO age-standard. 54 factor, we ranked countries in 1990 and 2010 by the age-standardised rates for each outcome measure. We compared China outcomes to the 18 other countries that are members of the G20 (the 20th member is the European Union). The G20 is the set of developed and developing countries identifi ed as global agenda setters. Comparisons of China with this group provide insights into China's standing relative to this set of developed or rapidly developing countries. For each quantity of interest in the GBD, 1000 draws were taken from the posterior distribution. We computed ranks across causes and percentage change from 1990 to 2010 at the draw level. We report 95% uncertainty intervals for ranks. For percentage change from 1990 to 2010 com puted at the level of each draw, we report the median percentage change, which is less sensitive to extreme values than the mean percentage change. For a specifi c country and cause, we tested whether a country was signifi cantly greater than the G20 mean, indistin guish able from the mean, or below the mean.
Role of the funding source
The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had fi nal respon sibility to submit for publication. Changes in age-specifi c mortality rates in China from 1990 to 2010 varied widely by age and sex (fi gure 1). Under-5 mortality rates declined by nearly 70% (95% UI 61·3-77·9). We noted declines in female adult mortality with declines in excess of 50% for age groups 0 years to 30-34 years. Progress in reduction of male mortality was substantially worse than that noted for women. Figure 1 shows comparative progress in reduction of age-specifi c mortality with other G20 countries. For men, China's of the G20. Shaded areas show 95% uncertainty intervals (UI). In some cases, the 95% UI has an upper and lower bound equal to the rank of the mean death rate. Countries have been ranked such that the best performer is ranked as one for each indicator. HIV/AIDS and tuberculosis
Results
HIV disease resulting in other specifi ed or unspecifi ed diseases
Diarrhoea, lower respiratory infections, meningitis, and other common infectious diseases
Typhoid and paratyphoid fevers
Respiratory syncytial virus pneumonia 56·1 (39·4-74·7)
Other lower respiratory infections 69·2 (53·4-93·3)
Neglected tropical diseases and malaria 
Hypertensive disorders of pregnancy
Neonatal encephalopathy (birth asphyxia/birth trauma)
Sepsis and other infectious disorders of the newborn baby
Other communicable, maternal, neonatal, and nutritional disorders
Sexually transmitted diseases excluding HIV
Other sexually transmitted diseases
Non-communicable diseases 5937·8 (5679·4-6331·6) 7017·1 (6663·3-7310·2) 18·7 708·5 (678·0-754·9) 509·4 (483·6-530·3) -27·8
Neoplasms
Liver cancer secondary to hepatitis B
Liver cancer secondary to hepatitis C 42·5 (36·1-51·8)
Liver cancer secondary to alcohol use
Other liver cancer
Trachea, bronchus, and lung cancers 260·2 (216·2-372·9)
Colon and rectum cancers Cancer of other part of pharynx and oropharynx
Gallbladder and biliary tract cancer
Kidney and other urinary organ cancers
Brain and nervous system cancers
Cardiovascular and circulatory diseases
Haemorrhagic and other non-ischemic stroke
Cardiomyopathy and myocarditis
Atrial fi brillation and fl utter
Other cardiovascular and circulatory diseases
Interstitial lung disease and pulmonary sarcoidosis
Other chronic respiratory diseases
Cirrhosis of the liver
Cirrhosis of the liver secondary to hepatitis B
Cirrhosis of the liver secondary to hepatitis C
Cirrhosis of the liver secondary to alcohol use
Other cirrhosis of the liver
Gastritis and duodenitis
Paralytic ileus and intestinal obstruction without hernia
Gall bladder and bile duct disease 
Alzheimer's disease and other dementias
Mental and behavioural disorders
Other mental and behavioural disorders
Diabetes, urogenital, blood, and endocrine diseases
Chronic kidney disease due to diabetes mellitus
Chronic kidney disease due to hypertension
Urinary diseases and male infertility
Tubulointerstitial nephritis, pyelonephritis, and urinary tract infections
Haemoglobinopathies and haemolytic anaemias
Other haemoglobinopathies and haemolytic anaemias
Other endocrine, nutritional, blood, and immune disorders
Other musculoskeletal disorders
Other non-communicable diseases
Cleft lip and cleft palate
(Continues on next page) relative rank in terms of age-specifi c mortality was lower than the G20 average at ages older than 50 years and relatively little changed between 1990 and 2010. For women and girls, however, we noted a substantial relative improvement, with ranks improving from 16th to 10th in the age groups 15-19 years through to 50-54 years. Although we noted a relative improvement for women older than 60 years, the improvement was less pronounced. Table 2 shows the number of deaths and the age-standardised death rate for each cause in 1990 and 2010. Communicable, maternal, neonatal, and nutritional disorders have declined by 59·5% (95% UI 54·4-63·8). Among these disorders, however, the large increase in HIV deaths is notable. The number of deaths from non-communicable disease rose from 5·9 million (5·7-6·3) to 7·0 million (6·7-7·3), but agestandardised death rates declined 27·8% (24·2-33·1); 
Skin and subcutaneous diseases
Abscess, impetigo, and other bacterial skin diseases
Other skin and subcutaneous diseases
Motorised vehicle with three or more wheels
Unintentional injuries other than transport injuries
Fire, heat, and hot substances
Self-harm and interpersonal violence
Assault by other means China has made substantial progress in reduction of the number of child deaths from 1·0 million (95% UI 0·9-1·1 million) in 1990 to 213 0000 (179 600-260 700) in 2010 (table 3) . During this period, the main causes of child mortality also changed. The top fi ve specifi c causes, accounting for 59·7% (51·7-69·1) of child deaths in 2010 were (in order of frequency) congenital anomalies, preterm birth complications, lower respiratory infections, neonatal encephalopathy, and drowning. Diarrhoeal diseases were ranked sixth (95% UI fi fth to seventh) in 1990 but accounted for 0·9% (95% UI 0·6-1·3) of child deaths in 2010, and measles were ranked seventh (sixth to 13th) in 1990 but accounted for 0·2% (95% UI <0·05-0·4) of child deaths in 2010. Figure 2 shows the striking transition in YLLs that took place in China between 1990 and 2010. The number of YLLs attributable to neonatal causes, diarrhoea, pneumonia, and other infectious causes and injuries in children declined profoundly in this period. At the same time, a shift occurred towards a large number of cardiovascular and cancer YLLs at older ages with a notable peak in cancer YLLs in the 55-59 year age group in 2010. The number, age pattern, and composition of injury YLLs also changed: we noted increases and shifts to older ages in transport injuries and large declines in intentional injuries. Figure 3 shows the transition in leading causes of YLLs from 1990 to 2010. We noted striking declines in major communicable and neonatal causes of premature mortality: lower respiratory infections moved from fi rst (95% UI fi rst to third) to ninth (eighth to 11th); neonatal encephalopathy dropped 14 ranks (sixth to 20th); preterm birth complications dropped ten ranks (ninth to 19th); a 77% (95% UI 72-84) decline in YLLs from tuberculosis led it to drop from 15th (13th to 16th) to 29th (26th to 35th); and diarrhoea and meningitis also had substantial improvements. YLLs from stroke, ischaemic heart disease, road injury, lung cancer, liver cancer, colorectal cancer, and diabetes increased. Although population ageing was a key driver of these increases, age-standardised YLL rates (data not shown) for ischaemic heart disease, road injury, 
Other communicable, maternal, neonatal, and nutritional diseases lung cancer, and diabetes also increased between 1990 and 2010. Several disorders that did not increase in incidence remained leading causes of YLLs in 2010: chronic obstructive pulmonary disease, stomach cancer, selfharm, oesophageal cancer, drowning, falls, and congenital anoma lies. The substantial decrease we noted in premature mortality from drowning deserves note. Incidence of HIV/AIDS increased strikingly in the 20-year period to become the 23rd biggest cause (20th to 29th) of YLLs. Figure 4 shows the levels of premature mortality in China relative to other members of the G20 in 2010. For men in China in 2010, age-standardised rates of years of life lost due to ischaemic heart disease, lower respiratory infections, cirrhosis, diabetes, preterm birth complications, chronic kidney diseases, HIV/AIDS, and tuberculosis were signifi cantly better than the G20 mean. China had signifi cantly worse ranks than the mean for stroke, chronic obstructive pulmonary disease, liver cancer, stomach cancer, oesophageal cancer, leukaemia, drowning, and falls. The YLL rates of road injury and lung cancer for 2010 are indistinguishable from the mean but the absolute increase in YLLs from these causes is concerning. For women in China, we noted better than G20 average performance on ischaemic heart disease, lower respiratory infections, diabetes, breast cancer, preterm birth complications, chronic kidney diseases, cervical cancer, cirrhosis, and cardiovascular and circulatory diseases. We noted worse than G20 average outcomes for stroke, chronic obstructive pulmonary disease, road injury, self-harm, liver cancer, stomach cancer, oesoph ageal cancer, falls, drowning, and rheumatic heart disease. Even for conditions such as ischaemic heart disease, lung cancer, and diabetes (for which China was better than average in the G20 in 2010), rising rates suggest that this status might change in the near future.
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Putting premature mortality and disability together in terms of DALYs provides an overall picture of the leading health problems in China. Table 4 shows the number and rate of DALYs in 1990 and 2010 and the percentage change between 1990 and 2010. The top ten causes have prominent roles for cardiovascular disorders (stroke and ischaemic heart disease) and cancers (lung and liver). Two disorders that largely cause disability, low back pain and major depression, are also leading causes of DALYs. Four other disorders make up the top ten: chronic obstructive pulmonary disease, diabetes, road injuries, and falls, which all make up an important component of premature mortality and disability.
Appendix pp 7-8 ranks each country by the agestandardised DALY rate across the G20 for men and women in 2010. Men in China had higher than G20 average rates of DALYs caused by stroke, chronic obstructive pulmonary disease, liver cancer, stomach cancer, oesophageal cancer, and drowning. Chinese women had increased rates of DALYs caused by stroke, chronic obstructive pulmonary disease, road injury, self-harm, liver cancer, and stomach cancer. For some of the leading causes of disability, including low back pain and neck pain, China had rates that are indistinguishable from the G20 mean. Comparing 1990 (data not shown) with 2010, eight causes switched from signifi cantly better than average to indistinguishable from average: falls, congenital anomalies, neonatal encephalopathy, poison ings, rheumatic heart disease, hookworm, ascariasis, and cysticercosis. For ischaemic heart disease, road injury and lung cancer (for which China was below the G20 average in 2010), rising rates mean that this situation might soon change. 
HIV/AIDS and tuberculosis
HIV disease resulting in mycobacterial infection
Diarrhoea, lower respiratory infections, meningitis, and other common infectious diseases
694·8
Typhoid and paratyphoid fevers 772·9 (96·8-1455·1)
Lower respiratory infections 25 300·9 (20 527·7-29 014·8)
Respiratory syncytial virus pneumonia
Other lower respiratory infections 3444·0 (2318·6-5218·0)
Neglected tropical diseases and malaria 8656·2 (5002·0-16 670·9) 
Neonatal encephalopathy (birth asphyxia/ birth trauma) Protein-energy malnutrition
Sexually transmitted diseases excluding HIV 
Liver cancer secondary to hepatitis B 3944·8 (3240·8-4694·3)
Liver cancer secondary to hepatitis C 1094·2 (907·5-1303·4)
Trachea, bronchus, and lung cancers
Colon and rectum cancers
Cancer of other part of pharynx and oropharynx
Gallbladder and biliary tract cancer Hodgkin's disease 64·7 (42·7-98·6)
Cardiovascular and circulatory diseases 45 267·9 
Cirrhosis of the liver
Cirrhosis of the liver secondary to hepatitis C 1035·7 (728·1-1210·3)
Gall bladder and bile duct disease
Other digestive diseases
Alzheimer's disease and other dementias 957·3 (732·6-1179·8)
Mental and behavioural disorders 24 450·5 (20 025·4-29 182·9) 
Attention-defi cit hyperactivity disorder
Diabetes, urogenital, blood, and endocrine diseases 13 110·6 (10 822·3-16 111·4)
Other endocrine, nutritional, blood, and immune disorders 
Other chromosomal abnormalities
Skin and subcutaneous diseases 5604·0 (3661·2-8513·9)
Other skin and subcutaneous diseases 685·4 (318·1-1295·3)
Refraction and accommodation disorders 564·9 (425·6-743·0)
Other hearing loss
Other sense organ diseases 21·4 (7·3-50·2) 
Adverse eff ects of medical treatment
Self-harm and interpersonal violence 10 773·5 (7173·7-12 847·8)
Assault by other means Although the burden of suicide, drowning, and many injuries declined, the burden of road injuries and falls is increasing. The rise of non-communicable diseases and chronic disability is fuelled by a shift away from risks for communicable diseases in children toward those for non-communicable diseases in adults. The one child policy in China implies the demographic shifts contributing to this rapid transition in health problems will intensify in the coming decades. China has had remarkable success in decreasing death rates and disability from communicable diseases. Deaths from diarrhoea and lower respiratory infections in children younger than 5 years declined by 90% in the two decades from 1990. DALYs caused by tuberculosis dropped by about 71%. We also noted large declines for incidence of infection with intestinal nematodes, meningitis, tetanus, measles, and diarrhoea. The speed of some of these declines provides a model for other developing countries. Communicable disease-control challenges, however, are not over. The burden of HIV increased between 1990 and 2010 (table 2). 213 000 (95% UI 179 600-260 700) children younger than 5 years died in 2010, almost 60% of them from communicable, neonatal, and nutritional causes. Subnational assess ments would probably reveal that the burden of communicable diseases is high in some poor provinces. China faces challenges dealing with the ongoing risk of pandemic infl uenza. The 2013 outbreak of H7N9 shows how the interaction between animal and human populations continues to lead to new epidemics. Through the internet-based surveillance system run by the Chinese CDC, early detection of the fi rst human cases of H7N9 led to a coherent response. Despite progress, continued attention to the unfi nished agenda for communicable disease control is required and ongoing epidemic surveillance and response is a necessity.
The burden of diseases attributable to individual behaviours and practices is steadily rising. The most important behaviours included diets low in fruit, high in sodium and low in whole grains, smoking, alcohol, and physical inactivity. Smoking prevalence in China for men is 52·9% (one of the highest rates in the world) and for women is 2·4% (one of the lowest), 55 and second-hand smoke exposure is as high as 72·4%. 23, 56 The fraction of deaths attributable to tobacco increased from 12·8% (9·9-16·9) in 1990 to 16·4% (12·8-19·9) in 2010 (appendix p 10) and will increase because of the lag between consumption and death rates. The aggregation of 14 components of diet was the leading risk factor for DALYs in China, including the consumption of sodium and inadequate intake of fruit, whole grains, and nuts and seeds. Reliable data from the national nutrition surveys show that even rural Chinese diets dominated by rice are low in fruit, high in sodium, low in whole grains, and low in nuts and seeds. Rising incomes and a larger fraction of the population living to older ages mean that the burden attributable to these behaviours will increase. The extraordinary pace of urbanisation in China might exacerbate this trans formation. The urban population in China has more than tripled in the past 30 years and the rate of urbanisation is accelerating. 57, 58 Although urbanisation off ers opportunities for improvements in population health in China (such as access to improved health care and basic infrastructure), it also can lead to substantial health risks including ambient air pollution, occupational and traffi c hazards, and poor diet and little physical activity. Associated social and economic challenges will accompany these shifts. For example, the ratio of the population older than 65 years to the workingaged population (aged 20-64 years) was 0·127 in 2010 and is expected to rise to 0·184 in 2020 and 0·26 in 2030. 2 The physical environment is an important driver of health in China. High levels of PM2·5, particularly in eastern China, have made ambient air pollution the fourth leading risk factor for DALYs. 59 Use of solid fuels-in particular coal in inadequately ventilated homes-also contributes to excess mortality. 59 Policies to change the physical layout of the road system and vehicle safety equipment might need to be enacted to restrict the burden of road injuries. 59 Physical activity might also be infl uenced by urban layout. Actions to address the physical environment, however, are far beyond the scope of the National Health and Family Planning Commission. Addressing these new and substantial risks to Chinese health will require multisectorial action at national, provincial, and local levels. Such action will need careful documentation of the health harms at a local level and the potential for aff ordable alternative policies to reduce these harms.
Rapid reductions in fertility and age-specifi c mortality rates have led to many more Chinese individuals living to an old age, when rates of chronic disability are high. Incidence of health loss and health-care costs from mental disorders, musculoskeletal disorders, neurological disorders, and vision and hearing loss will steadily rise. China needs to plan for how the health system can prevent and manage these disorders cost-eff ectively. Along with Japan, South Korea, and Mexico, China seems to benefi t from lower rates of major depression, anxiety disorders, and low back pain than do other members of the G20. This fi nding, however, has been challenged; true rates might be higher. 36 Our fi ndings on these rates are based on the careful assessment of all the available evidence; resolution will require more in-depth research on the potential for reporting biases in China and other countries in east Asia. The rise of chronic disability also has implications for the types of health workers China will need in the next 10-20 years; disciplines such as psychiatry, rheuma tology, rehabilitation medicine, audiology, and ophthal mology might need increased investment. The recent adoption of China's fi rst mental health law is a positive development in this area. The key obstacle China confronts in strengthening its public health and primary health care is a shortage of human resources. Although the Chinese Government has identifi ed the training of family doctors as a top priority 60 (and plans to train 300 000 of them in the next 10 years), these targets seem challenging to reach. Retention of qualifi ed health professionals in rural areas, especially in poor regions, has been diffi cult.
Compared with many countries, China is relatively unique in having fi ve cancers in the top 15 causes of premature mortality (Mexico, for example, has none): lung, liver, stomach, oesophageal, and colorectal. Of these cancers, the burden of lung, liver, and colorectal cancers increased between 1990 and 2010. China also has worse than G20 average rates for these cancers and oesophageal cancer. What are the policy options for China to address this unusually high burden of selected cancers? Tobacco and diet can account for important shares of stomach, colorectal, and lung cancers. Aggressive tobacco control and national eff orts to encourage changes in diet will be important. Hepatitis B is related to 54·2% (95% UI 49·5-58·8) of the increasing burden of liver cancer; immunisation programmes will lead eventually to reductions but, because the median age of liver cancer burden is 55 years, several decades will need to pass before the eff ect of vaccination can substantially reduce the burden of this cancer. Benefi ts from screening and treatment for colorectal cancer 61 should be assessed as to whether they are cost eff ective for China. Access to improved screening and treatment might also lead to improved outcomes for other cancers such as breast and cervical cancers.
Stroke and ischaemic heart disease accounted for 15·2% (13·3-16·6) of DALYs in 2010. DALY rates from stroke are nearly twice as high as ischaemic heart disease. Age-standardised rates for ischaemic heart disease increased between 1990 and 2010, although stroke rates in China were relatively constant. Increased blood pressure is the second leading risk factor in China ahead of tobacco consumption. Increased fasting plasma glucose and total cholesterol are also important risks of DALYs. Public health programmes to reduce tobacco consumption, sodium intake, and change other dietary risks are clearly important strategies for tackling of cardiovascular diseases in China. Primary care can also be a platform for delivery of interventions such as the detection and pharmacological management of raised blood pressure and cholesterol, and screening and management of diabetes, and impaired glucose tolerance. Because of China's hospital-centred health system, strengthening primary care to handle these and other problems will require a shift in policy focus. The massive declines in rates of death from ischaemic heart disease in many high-income countries have also been attributable to improved management of acute cardiac events and post-event care. [62] [63] [64] [65] [66] China increasingly needs to provide access to high-quality medical services in communities with rising rates of cardiovascular diseases.
The Chinese Government needs to take responsibility for expansion of prevention strategies for behavioural risks; even small reductions in these risks could generate substantial health benefi ts. Subsidies, taxation, regulation, and information campaigns need to be prioritised to reduce tobacco use and exposure to second-hand smoke, increase consumption of fruits, whole grain, nuts, and seeds, reduce salt intake, increase physical activity, and reduce alcohol consumption. Eff ective policies will need to be multisectorial, engaging other sectors such as employment, income maintenance, social welfare, housing, education, and the mass media. To engender multisectorial action, the Chinese Government needs to defi ne the goals and indicators for health development, monitor key health risk factors, select intervention strategies, and track policy implementation at a national level. This strategy will not only improve the levels of health status of the population, but contribute to sustainable development of the Chinese economy and society.
This analysis of the burden of disease in China has several important limitations. The results have the same limitations as GBD 2010. 1, [23] [24] [25] [26] [27] [28] [29] In GBD 2010, no data existed for some of the 1160 disabling sequelae for some or even many of the countries. Results have been informed by several data sources available for China but for some disorders the data are weak or absent (eg, autism, cannabis dependence, endometriosis, and genital prolapse). In other cases, substantial diff erences exist between the available data sources (eg, for some cancers the cause of death data and population-based cancer registry data are inconsistent in some age groups). The reporting of UIs provides the reader with some information on the extent of the information available for China. Uncertainty could, for various reasons such as unrecognised bias in published studies, still be under estimated. The analysis of risk factors has focused on proximal and behavioural risks. The important role of social determinants 67 was not quantifi ed in the GBD 2010 because of a dearth of available data and suffi cient evidence. The assessment of YLDs depends crucially on the validity of the disability weights measured by Salomon and colleagues. 27 Although investigation across several countries reported no evidence of systematic diff er ences; disability weights obtained in a national survey in China could be diff erent from other countries. 68, 69 Most importantly, a national analysis for a country as large and diverse as China could mask substantial variations in key outcomes. For example, the HIV epidemic is very concentrated in some provinces. 70, 71 The rapid transition towards non-communicable diseases and disability is probably more advanced in eastern provinces. In view of improvements in some data systems in the previous decade, the possibility of bias exists in the measurement of some diseases overtime. We believe that the substantial eff orts to correct for these biases that are part of the GBD method minimises this possibility.
In view of the pace of health change in China, the burden of diseases, injuries, and risk factors should be monitored every year. Annual assessments along with subnational detail at the provincial level ought to be undertaken. Key developments in the health infor mation system that are underway will facilitate such an analysis. Development of a complete national vital events registration system with certifi cation of cause of death would strikingly aid in this endeavour. In the previous 2 years alone, a rapid expansion has occurred in coverage of cause of death certifi cation so that more than half of all deaths were captured in 2012. The national internet case reporting system can provide local level detail on 39 diseases since 2004. Several national surveys are underway or planned with large sample sizes. Ensuring that the various surveillance systems and topic-specifi c national surveys ultimately combine to provide a coherent picture of the prevalence of major diseases, injuries, and risk factors at the provincial level will also reduce the role of statistical estimation in generating burden of disease results. Robust annual assessments of the burden will provide China with a powerful method to benchmark progress against developed and other rapidly developing nations and assess where investments and policy action have been eff ective. Setting priorities for the health system, however, will also need information on the costs and consequences of diff erent policy options, a better under standing of health inequalities and the capacity of the health system to implement change that is both effi cient and fair.
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